rs9580312
From SNPedia
Orientation | plus |
Stabilized | plus |
Make rs9580312(A;A) |
Make rs9580312(A;G) |
Make rs9580312(G;G) |
Reference | GRCh38 38.1/141 |
Chromosome | 13 |
Position | 22179954 |
is a | snp |
is | mentioned by |
dbSNP | rs9580312 |
dbSNP (classic) | rs9580312 |
ClinGen | rs9580312 |
ebi | rs9580312 |
HLI | rs9580312 |
Exac | rs9580312 |
Gnomad | rs9580312 |
Varsome | rs9580312 |
LitVar | rs9580312 |
Map | rs9580312 |
PheGenI | rs9580312 |
Biobank | rs9580312 |
1000 genomes | rs9580312 |
hgdp | rs9580312 |
ensembl | rs9580312 |
geneview | rs9580312 |
scholar | rs9580312 |
rs9580312 | |
pharmgkb | rs9580312 |
gwascentral | rs9580312 |
openSNP | rs9580312 |
23andMe | rs9580312 |
SNPshot | rs9580312 |
SNPdbe | rs9580312 |
MSV3d | rs9580312 |
GWAS Ctlg | rs9580312 |
GMAF | 0.2287 |
Max Magnitude | 0 |
? | (A;A) (A;G) (G;G) | 28 |
---|---|---|
|
GWAS snp | |
---|---|
PMID | [PMID 23648065] |
Trait | Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs) |
Title | Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan. |
Risk Allele | G |
P-val | 8E-6 |
Odds Ratio | 1.33 [1.12-1.581] |